SmallCaps
ASX:IDTPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

IDT Australia Ltd

$0.046
Day Range
$0.046 – $0.046
52 Week Range
$0.030 – $0.070
Volume
0.00
Avg Volume (10D)
137.81K

Price Chart

OHLC · volume · moving averages

$0.046-$0.004 (-8.00%)over 6M
Hi$0.051Lo$0.030
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today's trading range

Open
$0.046
Previous Close
$0.046
Day High
$0.046
Day Low
$0.046
52 Week High
$0.070
52 Week Low
$0.030

Valuation

Fundamental multiples

Market Cap
0.00
Shares Outstanding
0.00
Price to Book
1.12

Trading Activity

Volume & order book

Volume
0.00
Value Traded
0.00
Bid
$0.046 × 229,293
Ask
$0.050 × 157,423

Performance

Returns across timeframes

1 Day
4.17%
5 Day
19.05%
13 Week
35.14%
52 Week
-23.08%
YTD
-1.96%

Technical Indicators

Momentum & moving averages

RSI (14)
55.01
50-Day SMA
$0.039
200-Day SMA
$0.043

— From the desk

Latest News

IDT Australia Reports Operational Improvements with New Leadership Team and Realignment Strategy
Biotechnology

IDT Australia Reports Operational Improvements with New Leadership Team and Realignment Strategy

IDT Australia (ASX: IDT) reports improving six-month ops under a new leadership team and realignment strategy; revenue up 20% to $8.4m, EBITDA losses narrowed.

IDT Australia to pioneer national ADC manufacturing with Victorian government grant
Biotechnology

IDT Australia to pioneer national ADC manufacturing with Victorian government grant

Pharmaceutical manufacturing company IDT Australia (ASX: IDT) has been awarded a grant by the Victoria state government to partly fund the establishment of Australia’s first current good manufacturing practice antibody-drug-conjugate (ADC) manufacturing facility. The grant, provided by the Victorian Industry Investment Fund stream of the Victorian Jobs and Investment Fund, will support IDT Australia’s new […]

Cann to supply medicinal cannabis products to EU and UK, IDT will manufacture
Industrials & Juniors

Cann to supply medicinal cannabis products to EU and UK, IDT will manufacture

Australian cannabis developer Cann Group (ASX: CAN) has signed two agreements for the supply of medicinal cannabis-formulated oil and dried flower products to markets in the United Kingdom and European Union. The first deal is with UK-based Astral Health for the supply of oils including high THC (tetrahydrocannabinol), high CBD (cannabidiol) and a balanced formulation […]

Cann Group and IDT Australia move closer to bringing medicinal cannabis products to market
Biotechnology

Cann Group and IDT Australia move closer to bringing medicinal cannabis products to market

Cann Group (ASX: CAN) and IDT Australia (ASX: IDT) are closer to producing their first medicinal cannabis products with GMP extraction activities now underway. Once extracted, the resin will be used as an active pharmaceutical ingredient for either purchase or to produce GMP medicinal cannabis oil products at IDT’s facilities. The next step for the […]